Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Triglycerides measurement
|
1418 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.800 | 1.000 | 6 | 2011 | 2019 | |||||
Serum total cholesterol measurement
|
1243 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.800 | 1.000 | 4 | 2012 | 2019 | |||||
Arthritis, Gouty
|
2356 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 3 | 2010 | 2013 | |||||
Glomerular Filtration Rate
|
1033 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 3 | 2017 | 2019 | |||||
Gout
|
2354 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 3 | 2010 | 2013 | |||||
Coronary Artery Disease
|
1577 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 2 | 2018 | 2019 | |||||
Phospholipid measurement
|
306 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 2 | 2011 | 2013 | |||||
Uric acid measurement (procedure)
|
1463 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.800 | 1.000 | 2 | 2009 | 2010 | |||||
Blood Pressure
|
220 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
C-reactive protein measurement
|
624 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Cardiovascular Diseases
|
711 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Chronic Kidney Diseases
|
306 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Coronary Arteriosclerosis
|
440 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Coronary heart disease
|
1178 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Creatinine measurement, serum (procedure)
|
243 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||
Crohn Disease
|
1147 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.800 | 1.000 | 1 | 2010 | 2010 | |||||
Diabetes
|
710 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Diabetes Mellitus
|
824 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Estradiol level result
|
75 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Estradiol measurement
|
75 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||
Fatty acid measurement
|
116 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||
Hypertriglyceridemia
|
169 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||
Leptin measurement
|
9 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Metabolic Syndrome X
|
591 | 0.763 | 0.240 | 2 | 27519736 | intron variant | T/C | snv | 0.68 | 0.700 | 1.000 | 1 | 2011 | 2011 |